[The 62nd Congress of the French Society of Internal Medicine, Dijon, 8-10 December 2010].
B
B
Lorcerie
D001691:Biological Therapy / Q000639:trends; D005602:France; D030342:Genetic Diseases, Inborn / Q000628:therapy; D005853:Geriatrics; D006801:Humans; D006937:Hypercholesterolemia / Q000628:therapy; D006976:Hypertension, Pulmonary / Q000628:therapy; D007388:Internal Medicine; D008180:Lupus Erythematosus, Systemic / Q000628:therapy; D009101:Multiple Myeloma / Q000628:therapy; D009369:Neoplasms / Q000150:complications; D011643:Publishing; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000628:therapy; D012595:Scleroderma, Systemic / Q000628:therapy; D012955:Societies, Medical; D013927:Thrombosis / Q000209:etiology